Can DIY insulin algorithms match commercial systems for pregnant women with type 1 diabetes?

NCT ID NCT06654713

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This observational study follows 1,000 pregnant people with type 1 diabetes who use either a commercial or an open-source automated insulin delivery (AID) system. Researchers aim to compare maternal and neonatal outcomes, blood sugar control, and emotional well-being between the two groups. Participants share device data, complete surveys, and allow access to medical records.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
automated insulin delivery (AID) systems — both commercial and open-source versions
What this could lead to
If successful, this could help identify which type of automated insulin system works best for managing diabetes during pregnancy, potentially improving outcomes for mothers and babies.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in user behavior or system settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN DEPENDENT DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94158, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.